Metabolomics by NMR Combined with Machine Learning to Predict Neoadjuvant Chemotherapy Response for Breast Cancer

SIMPLE SUMMARY: Neoadjuvant chemotherapy (NACT) is offered to breast cancer (BC) patients to downstage the disease. However, some patients may not respond to NACT, being resistant. We used the serum metabolic profile by Nuclear Magnetic Resonance (NMR) combined with disease characteristics to differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardoso, Marcella R., Silva, Alex Ap. Rosini, Talarico, Maria Cecília R., Sanches, Pedro H. Godoy, Sforça, Maurício L., Rocco, Silvana A., Rezende, Luciana M., Quintero, Melissa, Costa, Tassia B. B. C., Viana, Laís R., Canevarolo, Rafael R., Ferracini, Amanda C., Ramalho, Susana, Gutierrez, Junier Marrero, Guimarães, Fernando, Tasic, Ljubica, Tata, Alessandra, Sarian, Luís O., Cheng, Leo L., Porcari, Andreia M., Derchain, Sophie F. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600495/
https://www.ncbi.nlm.nih.gov/pubmed/36291837
http://dx.doi.org/10.3390/cancers14205055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600495/
https://www.ncbi.nlm.nih.gov/pubmed/36291837
http://dx.doi.org/10.3390/cancers14205055

Ejemplares similares